209106976	209106976	CD	B-NP	O
|	|	NN	I-NP	O
OAUOMC	OAUOMC	NN	I-NP	O
|	|	NN	I-NP	O
00907967	00907967	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2619553	2619553	CD	B-NP	O
|	|	CC	I-NP	O
10/7/2005	10/7/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
chf	chf	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/22/2005	5/22/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/18/2005	3/18/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
WYMS	WYMS	NNP	B-NP	O
,	,	,	O	O
MOSE	MOSE	NNP	B-NP	O
100-68-32-5	100-68-32-5	CD	I-NP	O
Ve	Ve	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/22/05	10/22/05	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CANTEY	CANTEY	NNP	B-NP	O
,	,	,	O	O
PEDRO	PEDRO	NNP	B-NP	O
ANTONIA	ANTONIA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/16/05	10/16/05	CD	B-NP	O
by	by	IN	B-PP	O
FLEEK	FLEEK	NN	B-NP	B-protein
,	,	,	O	O
ROSCOE	ROSCOE	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
55106111	55106111	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ho	ho	VB	B-VP	O
aware	aware	JJ	B-ADJP	O
.	.	.	O	O

will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/6/05	9/6/05	CD	B-NP	O
by	by	IN	B-PP	O
BALLOW	BALLOW	NNP	B-NP	O
,	,	,	O	O
THANH	THANH	NNP	B-NP	O
LEIF	LEIF	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ALLOPURINOL	ALLOPURINOL	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/16/05	10/16/05	CD	B-NP	O
by	by	IN	B-PP	O
BLYZE	BLYZE	NNP	B-NP	O
,	,	,	O	O
JOHNSON	JOHNSON	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
55106111	55106111	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ho	ho	VB	B-VP	O
aware	aware	JJ	B-ADJP	O
.	.	.	O	O

will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/6/05	9/6/05	CD	B-NP	O
by	by	IN	B-PP	O
YEAROUT	YEAROUT	NNP	B-NP	O
,	,	,	O	O
JAIME	JAIME	NNP	B-NP	O
BUSTER	BUSTER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
61830769	61830769	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
FESO4	FESO4	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	B-protein
FOLATE	FOLATE	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FOLIC	FOLIC	NN	I-NP	I-protein
ACID	ACID	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
200	200	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/20	9/20	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
400	400	CD	I-NP	O
ZAROXOLYN	ZAROXOLYN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOLAZONE	METOLAZONE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/20	9/20	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
please	please	VB	B-INTJ	O
give	give	VB	B-VP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
before	before	IN	B-PP	O
lasix	lasix	CD	B-NP	O
LOPRESSOR	LOPRESSOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

OXYCODONE	OXYCODONE	IN	B-PP	O
5	5	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
PHENOBARBITAL	PHENOBARBITAL	NNP	I-NP	O
64.8	64.8	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/16/05	10/16/05	CD	B-NP	O
by	by	IN	B-PP	O
BOMPANE	BOMPANE	NNP	B-NP	O
,	,	,	O	O
TRINIDAD	TRINIDAD	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
55106111	55106111	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENOBARBITAL	PHENOBARBITAL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENOBARBITAL	PHENOBARBITAL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ho	ho	VB	B-VP	O
aware	aware	JJ	B-ADJP	O
.	.	.	O	O

will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/6/05	9/6/05	CD	B-NP	O
by	by	IN	B-PP	O
OLOFSON	OLOFSON	NNP	B-NP	O
,	,	,	O	O
JEFFEREY	JEFFEREY	NNP	B-NP	O
EDISON	EDISON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
PHENOBARBITAL	PHENOBARBITAL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
SENNA	SENNA	NN	I-NP	O
TABLETS	TABLETS	NN	I-NP	O
2	2	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/21	11/21	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/16/05	10/16/05	CD	B-NP	O
by	by	IN	B-PP	O
PINKHAM	PINKHAM	NNP	B-NP	O
,	,	,	O	O
LAVERNE	LAVERNE	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENOBARBITAL	PHENOBARBITAL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENOBARBITAL	PHENOBARBITAL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ho	ho	VB	B-VP	O
aware	aware	JJ	B-ADJP	O
.	.	.	O	O

will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
K-DUR	K-DUR	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
NMH	NMH	NN	B-NP	O
Potassium	Potassium	NN	I-NP	O
Chloride	Chloride	NN	I-NP	O
Policy	Policy	NN	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	B-protein
OXYCONTIN	OXYCONTIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
OXYCODONE	OXYCODONE	NNP	I-NP	I-protein
CONTROLLED	CONTROLLED	NNP	I-NP	I-protein
RELEASE	RELEASE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q12H	Q12H	NN	I-NP	I-protein
DIOVAN	DIOVAN	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
VALSARTAN	VALSARTAN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
80	80	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
38	38	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ho	ho	JJ	B-NP	O
aware	aware	JJ	I-NP	O
PROTONIX	PROTONIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Coumadin	Coumadin	NN	B-NP	O
check	check	NN	I-NP	O
,	,	,	O	O
dellsrea	dellsrea	NN	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
9/29	9/29	CD	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Night	Night	NNP	I-NP	O
,	,	,	O	O
4/19	4/19	CD	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
his	his	PRP$	B-NP	O
office	office	NN	I-NP	O
to	to	TO	B-VP	O
find	find	VB	I-VP	O
out	out	RP	B-PRT	O
what	what	WDT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
4/6/05	4/6/05	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
CRIT	CRIT	NN	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
MEPERIDINE	MEPERIDINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
,	,	,	O	O
SILDENAFIL	SILDENAFIL	NNP	B-NP	O
CITRATE	CITRATE	NNP	I-NP	O
,	,	,	O	O
GABAPENTIN	GABAPENTIN	NNP	B-NP	B-protein
,	,	,	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NN	B-NP	O
,	,	,	O	O
NITRATE	NITRATE	NN	B-NP	O
,	,	,	O	O
DIGOXIN	DIGOXIN	NN	B-NP	B-protein
,	,	,	O	O
AMLODIPINE	AMLODIPINE	NN	B-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
chf	chf	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
chf	chf	NN	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
VV	VV	NNP	I-NP	O
pacer	pacer	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Afib	Afib	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CVA	CVA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cerebrovascular	cerebrovascular	JJ	I-NP	O
accident	accident	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Peripheral	Peripheral	JJ	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Obesity	Obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PVD	PVD	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CRI	CRI	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
70	70	CD	B-NP	O
yo	yo	NN	I-NP	O
M	M	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
h/o	h/o	NN	I-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
wks	wk	NNS	I-NP	O
of	of	IN	B-PP	O
slowly	slowly	RB	B-NP	O
inc	inc	NN	I-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
girth	girth	NN	I-NP	O
,	,	,	O	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	I-NP	O
DOE	DOE	NN	I-NP	O
starting	start	VBG	B-VP	O
after	after	IN	B-PP	O
colonoscopy	colonoscopy	NN	B-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
then	then	RB	B-NP	O
,	,	,	O	O
wt	wt	NN	B-NP	O
inc	inc	NN	I-NP	O
approx	approx	VBP	B-VP	O
20	20	CD	B-NP	O
lbs	lb	NNS	I-NP	O
-LRB-	-LRB-	-LRB	B-NP	B-protein
``	``	``	I-NP	O
dry	dry	JJ	I-NP	O
''	''	''	I-NP	O
wt	wt	NN	I-NP	O
around	around	IN	B-PP	O
242	242	CD	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
AM	AM	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-protein
261	261	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
swears	swear	VBZ	B-VP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
sticking	stick	VBG	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
taking	take	VBG	B-VP	O
all	all	PDT	B-NP	O
his	his	PRP$	I-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
PND	PND	NN	B-NP	B-protein
and	and	CC	I-NP	O
occ	occ	NN	I-NP	O
dull	dull	NN	I-NP	O
CP	CP	NN	I-NP	O
4-6	4-6	CD	I-NP	O
min	min	NN	I-NP	O
in	in	IN	B-PP	O
length	length	NN	B-NP	O
usu	usu	NN	I-NP	O
with	with	IN	B-PP	O
exercise	exercise	NN	B-NP	O
,	,	,	O	O
last	last	JJ	B-NP	O
today	today	NN	I-NP	O
on	on	IN	B-PP	O
way	way	NN	B-NP	O
into	into	IN	B-PP	O
ED	ED	NN	B-NP	O
.	.	.	O	O

Spoke	Spoke	NN	B-NP	O
to	to	TO	B-PP	O
PCP	PCP	NN	B-NP	O
Sat	Sat	NNP	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
inc	inc	VBD	B-VP	O
his	his	PRP$	B-NP	O
zarox	zarox	NN	I-NP	O
from	from	IN	B-PP	O
2.5	2.5	CD	B-NP	O
to	to	TO	I-NP	O
5	5	CD	I-NP	O
qd	qd	NN	I-NP	O
before	before	IN	B-PP	O
200	200	CD	B-NP	O
po	po	NN	I-NP	O
qam	qam	NN	I-NP	O
lasix	lasix	NN	I-NP	O
without	without	IN	B-PP	O
effect	effect	NN	B-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
f/c	f/c	NN	I-NP	O
,	,	,	O	O
occ	occ	NN	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
still	still	RB	B-ADVP	O
since	since	IN	B-PP	O
colo	colo	NN	B-NP	O
,	,	,	O	O
stable	stable	JJ	B-NP	O
8	8	CD	I-NP	O
pillow	pillow	NN	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	B-protein
on	on	IN	B-PP	O
adm	adm	NN	B-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
CRI	CRI	NN	I-NP	O
,	,	,	O	O
Hct	Hct	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
inc	inc	NN	I-NP	O
WBC	WBC	NN	I-NP	O
,	,	,	O	O
1st	1st	CD	B-NP	O
set	set	VBP	B-VP	O
enz	enz	NN	B-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
143	143	CD	I-NP	I-protein
.	.	.	O	O

PE	PE	NN	B-NP	O
on	on	IN	B-PP	O
adm	adm	NN	B-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	O
15	15	CD	I-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
LLE	LLE	NN	I-NP	B-protein
and	and	CC	I-NP	I-protein
2	2	CD	I-NP	I-protein
+	+	SYM	I-NP	O
RLE	RLE	NN	I-NP	B-protein
edema	edema	SYM	B-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
usu	usu	NN	I-NP	I-protein
asymm	asymm	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
abd	abd	NN	B-NP	O
distention	distention	NN	I-NP	O
without	without	IN	B-PP	O
tenderness	tenderness	NN	B-NP	O
,	,	,	O	O
clear	clear	JJ	B-NP	O
lungs	lung	NNS	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
EKG	EKG	NN	B-NP	B-protein
paced	pace	VBD	B-VP	O
and	and	CC	O	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

Rx	Rx	NN	B-NP	O
100	100	CD	I-NP	O
iv	iv	NN	I-NP	O
lasix	lasix	NN	I-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
without	without	IN	B-PP	O
much	much	JJ	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

************************	************************	SYM	O	O
Hospital	Hospital	NN	B-NP	O
Course	Course	NN	I-NP	O
*******************************	*******************************	SYM	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
i	i	NN	B-NP	O
:	:	:	O	O
ROMI	ROMI	NN	B-NP	B-protein
x	x	SYM	O	I-protein
3	3	CD	B-NP	I-protein
negative	negative	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
,	,	,	O	O
cont	cont	VBP	B-VP	O
home	home	NN	B-NP	O
asa	asa	NN	I-NP	O
,	,	,	O	O
bb	bb	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
.	.	.	O	O

p	p	NN	B-NP	O
:	:	:	O	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
lasix	lasix	CD	B-NP	O
iv	iv	NN	I-NP	O
200	200	CD	B-NP	O
BID	BID	NN	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
diurhesis	diurhesis	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

260	260	CD	B-NP	O
lbs	lb	NNS	I-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
.	.	.	O	O

253	253	CD	B-NP	O
on	on	IN	B-PP	O
d/c	d/c	NN	B-NP	O
with	with	IN	B-PP	O
much	much	JJ	B-NP	O
improved	improved	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	O	O
pt	pt	NN	B-NP	O
eager	eager	JJ	B-ADJP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
.	.	.	O	O

Increased	Increase	VBN	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
lasix	lasix	CD	B-NP	O
to	to	TO	I-NP	O
200	200	CD	I-NP	O
PO	PO	NN	I-NP	O
bid	bid	NN	I-NP	O
with	with	IN	B-PP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
zaroxylin	zaroxylin	NN	I-NP	O
before	before	IN	B-PP	O
morning	morning	NN	B-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
f/u	f/u	NN	B-NP	O
by	by	IN	B-PP	O
CHF	CHF	NN	B-NP	O
nursing	nursing	NN	I-NP	O
service	service	NN	I-NP	O
to	to	TO	B-VP	O
adjust	adjust	VB	I-VP	O
lasix	lasix	NN	B-NP	O
if	if	IN	B-SBAR	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

Cont	Cont	JJ	B-NP	O
diovan	diovan	NN	I-NP	O
.	.	.	O	O

Clifton	Clifton	NNP	B-NP	O
Poisel	Poisel	NNP	I-NP	O
at	at	IN	B-PP	O
Vinday	Vinday	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
R	R	NNP	I-NP	O
:	:	:	O	O
tele	tele	NN	B-NP	O
while	while	IN	B-SBAR	O
active	active	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
Endo	Endo	NNP	I-NP	O
:	:	:	O	O
RISS	RISS	NN	B-NP	O
and	and	CC	I-NP	O
lantus	lantus	NN	I-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
wnl	wnl	NN	I-NP	O
.	.	.	O	O

Rheum	Rheum	NNP	B-NP	O
:	:	:	O	O
cont	cont	VB	B-VP	O
allopurinol	allopurinol	NN	B-NP	O
Heme	Heme	NNP	I-NP	O
:	:	:	O	O
INR	INR	NN	B-NP	O
1.8	1.8	CD	I-NP	O
,	,	,	O	O
restarted	restart	VBD	B-VP	O
coumadin	coumadin	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
coumadin	coumadin	NN	I-NP	O
:	:	:	O	O
takes	take	VBZ	B-VP	O
10MF	10MF	NN	B-NP	O
and	and	CC	O	O
12.5	12.5	CD	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
week	week	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
bleeding	bleed	VBG	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
be	be	VB	I-VP	O
f/u	f/u	NN	B-NP	O
at	at	IN	B-PP	O
liale	liale	NN	B-NP	O
hospital	hospital	NN	I-NP	O
on	on	IN	B-PP	O
9/29	9/29	CD	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
drawn	draw	VBN	B-VP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Creatinine	Creatinine	NN	B-NP	O
bumped	bump	VBD	B-VP	O
to	to	TO	B-PP	O
2.4	2.4	CD	B-NP	O
in	in	IN	B-PP	O
context	context	NN	B-NP	O
of	of	IN	B-PP	O
diurhesis	diurhesis	NN	B-NP	O
.	.	.	O	O

Improved	Improve	VBN	B-VP	O
to	to	TO	B-PP	O
2.2	2.2	CD	B-NP	O
on	on	IN	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
BMP	BMP	NN	B-NP	O
drawn	draw	VBN	B-VP	O
on	on	IN	B-PP	O
9/29	9/29	CD	B-NP	O
with	with	IN	B-PP	O
inr	inr	NN	B-NP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
stability	stability	NN	B-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Cont	Cont	NNP	B-NP	O
phenobarb	phenobarb	NN	I-NP	O
s/p	s/p	NN	I-NP	O
cva	cva	NN	I-NP	O
with	with	IN	B-PP	O
sz	sz	NN	B-NP	O
.	.	.	O	O

Level	Level	NNP	B-NP	O
21.9	21.9	CD	I-NP	O
Pain	Pain	NNP	I-NP	O
:	:	:	O	O
Cont	Cont	NNP	B-NP	O
oxycontin	oxycontin	NN	I-NP	O
and	and	CC	I-NP	O
oxycodone	oxycodone	NN	I-NP	O
for	for	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
weight	weight	NN	I-NP	O
yourself	yourself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
report	report	NN	B-NP	O
weights	weight	NNS	I-NP	O
to	to	TO	B-PP	O
norma	norma	NN	B-NP	O
osborne	osborne	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
only	only	JJ	I-NP	O
change	change	NN	I-NP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
Please	Please	NN	I-NP	O
take	take	NN	I-NP	O
lasix	lasix	NN	I-NP	O
200mg	200mg	CD	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
at	at	IN	B-PP	O
8am	8am	NN	B-NP	O
and	and	CC	I-NP	O
4pm	4pm	NN	I-NP	O
-	-	HYPH	O	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
before	before	IN	B-PP	O
your	your	PRP$	B-NP	O
morning	morning	NN	I-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
please	please	VB	B-INTJ	O
take	take	VB	B-VP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
zaroxylin	zaroxylin	NN	B-NP	B-protein
.	.	.	O	O

-	-	HYPH	O	O
if	if	IN	B-SBAR	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
is	be	VBZ	B-VP	O
increased	increase	VBN	I-VP	O
by	by	IN	B-PP	O
2	2	CD	B-NP	O
Lbs	Lb	NNS	I-NP	B-protein
or	or	CC	I-NP	O
more	more	JJR	I-NP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
jackie	jackie	NN	I-NP	O
hatstat	hatstat	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
nurse	nurse	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
4/19	4/19	CD	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Cretella	Cretella	NNP	I-NP	O
.	.	.	O	O

9/29	9/29	CD	B-NP	O
INR	INR	NN	I-NP	O
and	and	CC	I-NP	O
BMP	BMP	NN	I-NP	O
check	check	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
ZBELL	ZBELL	NNP	B-NP	B-cell_type
,	,	,	O	O
HONG	HONG	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PA461	PA461	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/22/05	10/22/05	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
24	24	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

